This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab
Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomes
Arthritis Res 2002, 4(Suppl 2):S6-S10 doi:10.1186/ar553
No comments have yet been made on this article.
